Compare $NEUP vs $VBS.AX | Chartloom

Compare

$NEUP vs $VBS.AX

NEUP

Neuphoria Therapeutics Inc

VBS.AX

Error

Compare $NEUP vs $VBS.AX

NEUPNeuphoria Therapeutics Inc

VBS.AX

Error

NEUPNeuphoria Therapeutics Inc

Market cap

$18M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-92.5%

YTD performance

-12.0%

52W performance

-81.7%

FCF yield

-68.1%

VBS.AX

Market cap

—

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

—

52W performance

—

FCF yield

—

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NEUP

VBS.AX

Not enough overlapping price history for this window.

Detailed metrics comparison

NEUP

Neuphoria Therapeutics Inc

VBS.AX

Market Cap

NEUP$18M

VBS.AX

Enterprise Value

NEUP$-2M

VBS.AX

Price

NEUP$3.36

VBS.AX

P/E Ratio

NEUPN/A

VBS.AX

P/S Ratio

NEUP15.45x

VBS.AX

EV/Sales

NEUP-1.44x

VBS.AX

EV/EBITDA

NEUP0.00x

VBS.AX

P/B Ratio

NEUP0.76x

VBS.AX

P/FCF Ratio

NEUPN/A

VBS.AX

EV/FCF

NEUP0.14x

VBS.AX

PEG Ratio

NEUPN/A

VBS.AX

Forward P/E (NTM)

NEUPN/A

VBS.AX

Forward P/S (NTM)

NEUPN/A

VBS.AX

Revenue (TTM)

NEUP$1M

VBS.AX

Revenue Growth (YoY)

NEUP-92.5%

VBS.AX

Forward Rev Growth

NEUP0.0%

VBS.AX

Gross Margin (TTM)

NEUP0.0%

VBS.AX

Operating Margin (TTM)

NEUP0.0%

VBS.AX

EBITDA Margin (TTM)

NEUP-779.0%

VBS.AX

Net Margin (TTM)

NEUP-1145.6%

VBS.AX

FCF Margin (TTM)

NEUP-1052.0%

VBS.AX

Net Income (TTM)

NEUP$-13M

VBS.AX

FCF (TTM)

NEUP$-12M

VBS.AX

EPS (TTM)

NEUP-$2.49

VBS.AX

ROE (TTM)

NEUP-5591.0%

VBS.AX

ROA (TTM)

NEUP-4222.0%

VBS.AX

ROIC (TTM)

NEUP-5583.0%

VBS.AX

Cash

NEUP$20M

VBS.AX

Debt

NEUP$34K

VBS.AX

Net Cash/Debt

NEUP$20M

VBS.AX

Current Ratio (TTM)

NEUP27.85x

VBS.AX

Quick Ratio (TTM)

NEUP27.33x

VBS.AX

Debt/Equity (TTM)

NEUP0.00x

VBS.AX

Debt/Assets (TTM)

NEUP0.0%

VBS.AX

Interest Coverage (TTM)

NEUPN/A

VBS.AX

Net Debt/EBITDA (TTM)

NEUP0.00x

VBS.AX

Beta

NEUP0.76

VBS.AX

52W Performance

NEUP-81.7%

VBS.AX

YTD Performance

NEUP-12.0%

VBS.AX

% from 52W High

NEUP-82.5%

VBS.AX

% from 52W Low

NEUP5.3%

VBS.AX

Asset Turnover (TTM)

NEUP0.04x

VBS.AX

FCF Yield (TTM)

NEUP-68.1%

VBS.AX

Earnings Yield (TTM)

NEUP-74.1%

VBS.AX

Dividend Yield (TTM)

NEUPN/A

VBS.AX

Rule of 40

NEUP-1,144.5

VBS.AX

EV/GP/RG

NEUPN/A

VBS.AX

Ticker research

View NEUP research View VBS.AX research

Metric	NEUP Neuphoria Therapeutics Inc	VBS.AX
Market & Valuation
Market Cap	$18M
Enterprise Value	$-2M
Price	$3.36
P/E Ratio	N/A
P/S Ratio	15.45x
EV/Sales	-1.44x
EV/EBITDA	0.00x
P/B Ratio	0.76x
P/FCF Ratio	N/A
EV/FCF	0.14x
PEG Ratio	N/A
Forward P/E (NTM)	N/A
Forward P/S (NTM)	N/A
Revenue & Growth
Revenue (TTM)	$1M
Revenue Growth (YoY)	-92.5%
Forward Rev Growth	0.0%
Profitability
Gross Margin (TTM)	0.0%
Operating Margin (TTM)	0.0%
EBITDA Margin (TTM)	-779.0%
Net Margin (TTM)	-1145.6%
FCF Margin (TTM)	-1052.0%
Net Income (TTM)	$-13M
FCF (TTM)	$-12M
EPS (TTM)	-$2.49
ROE (TTM)	-5591.0%
ROA (TTM)	-4222.0%
ROIC (TTM)	-5583.0%
Financial Health
Cash	$20M
Debt	$34K
Net Cash/Debt	$20M
Current Ratio (TTM)	27.85x
Quick Ratio (TTM)	27.33x
Debt/Equity (TTM)	0.00x
Debt/Assets (TTM)	0.0%
Interest Coverage (TTM)	N/A
Net Debt/EBITDA (TTM)	0.00x
Performance
Beta	0.76
52W Performance	-81.7%
YTD Performance	-12.0%
% from 52W High	-82.5%
% from 52W Low	5.3%
Efficiency & Yields
Asset Turnover (TTM)	0.04x
FCF Yield (TTM)	-68.1%
Earnings Yield (TTM)	-74.1%
Dividend Yield (TTM)	N/A
Other
Rule of 40	-1,144.5
EV/GP/RG	N/A
Ticker research	View NEUP research	View VBS.AX research

Valuation

Growth & revenue

Profitability & performance

Detailed metrics comparison

NEUP

Neuphoria Therapeutics Inc

VBS.AX

Market Cap

NEUP$18M

VBS.AX

Enterprise Value

NEUP$-2M

VBS.AX

Price

NEUP$3.36

VBS.AX

P/E Ratio

NEUPN/A

VBS.AX

P/S Ratio

NEUP15.45x

VBS.AX

EV/Sales

NEUP-1.44x

VBS.AX

EV/EBITDA

NEUP0.00x

VBS.AX

P/B Ratio

NEUP0.76x

VBS.AX

P/FCF Ratio

NEUPN/A

VBS.AX

EV/FCF

NEUP0.14x

VBS.AX

PEG Ratio

NEUPN/A

VBS.AX

Forward P/E (NTM)

NEUPN/A

VBS.AX

Forward P/S (NTM)

NEUPN/A

VBS.AX

Revenue (TTM)

NEUP$1M

VBS.AX

Revenue Growth (YoY)

NEUP-92.5%

VBS.AX

Forward Rev Growth

NEUP0.0%

VBS.AX

Gross Margin (TTM)

NEUP0.0%

VBS.AX

Operating Margin (TTM)

NEUP0.0%

VBS.AX

EBITDA Margin (TTM)

NEUP-779.0%

VBS.AX

Net Margin (TTM)

NEUP-1145.6%

VBS.AX

FCF Margin (TTM)

NEUP-1052.0%

VBS.AX

Net Income (TTM)

NEUP$-13M

VBS.AX

FCF (TTM)

NEUP$-12M

VBS.AX

EPS (TTM)

NEUP-$2.49

VBS.AX

ROE (TTM)

NEUP-5591.0%

VBS.AX

ROA (TTM)

NEUP-4222.0%

VBS.AX

ROIC (TTM)

NEUP-5583.0%

VBS.AX

Cash

NEUP$20M

VBS.AX

Debt

NEUP$34K

VBS.AX

Net Cash/Debt

NEUP$20M

VBS.AX

Current Ratio (TTM)

NEUP27.85x

VBS.AX

Quick Ratio (TTM)

NEUP27.33x

VBS.AX

Debt/Equity (TTM)

NEUP0.00x

VBS.AX

Debt/Assets (TTM)

NEUP0.0%

VBS.AX

Interest Coverage (TTM)

NEUPN/A

VBS.AX

Net Debt/EBITDA (TTM)

NEUP0.00x

VBS.AX

Beta

NEUP0.76

VBS.AX

52W Performance

NEUP-81.7%

VBS.AX

YTD Performance

NEUP-12.0%

VBS.AX

% from 52W High

NEUP-82.5%

VBS.AX

% from 52W Low

NEUP5.3%

VBS.AX

Asset Turnover (TTM)

NEUP0.04x

VBS.AX

FCF Yield (TTM)

NEUP-68.1%

VBS.AX

Earnings Yield (TTM)

NEUP-74.1%

VBS.AX

Dividend Yield (TTM)

NEUPN/A

VBS.AX

Rule of 40

NEUP-1,144.5

VBS.AX

EV/GP/RG

NEUPN/A

VBS.AX

Ticker research

View NEUP research View VBS.AX research

Metric	NEUP Neuphoria Therapeutics Inc	VBS.AX
Market & Valuation
Market Cap	$18M
Enterprise Value	$-2M
Price	$3.36
P/E Ratio	N/A
P/S Ratio	15.45x
EV/Sales	-1.44x
EV/EBITDA	0.00x
P/B Ratio	0.76x
P/FCF Ratio	N/A
EV/FCF	0.14x
PEG Ratio	N/A
Forward P/E (NTM)	N/A
Forward P/S (NTM)	N/A
Revenue & Growth
Revenue (TTM)	$1M
Revenue Growth (YoY)	-92.5%
Forward Rev Growth	0.0%
Profitability
Gross Margin (TTM)	0.0%
Operating Margin (TTM)	0.0%
EBITDA Margin (TTM)	-779.0%
Net Margin (TTM)	-1145.6%
FCF Margin (TTM)	-1052.0%
Net Income (TTM)	$-13M
FCF (TTM)	$-12M
EPS (TTM)	-$2.49
ROE (TTM)	-5591.0%
ROA (TTM)	-4222.0%
ROIC (TTM)	-5583.0%
Financial Health
Cash	$20M
Debt	$34K
Net Cash/Debt	$20M
Current Ratio (TTM)	27.85x
Quick Ratio (TTM)	27.33x
Debt/Equity (TTM)	0.00x
Debt/Assets (TTM)	0.0%
Interest Coverage (TTM)	N/A
Net Debt/EBITDA (TTM)	0.00x
Performance
Beta	0.76
52W Performance	-81.7%
YTD Performance	-12.0%
% from 52W High	-82.5%
% from 52W Low	5.3%
Efficiency & Yields
Asset Turnover (TTM)	0.04x
FCF Yield (TTM)	-68.1%
Earnings Yield (TTM)	-74.1%
Dividend Yield (TTM)	N/A
Other
Rule of 40	-1,144.5
EV/GP/RG	N/A
Ticker research	View NEUP research	View VBS.AX research